Skip to main
RENB
RENB logo

RENB Market Capitalization Overview

Market Cap: $25.08M as of Dec 12, 2025

$25.08M
$499.80K (2.03%)past month
As of Dec 12, 2025, RENB has a market capitalization of $25.08M. Over the past 30 days, its market cap has increased by 52.06%, while in the last 12 months, it has decreased by -81.49%.

Market capitalization represents the total value of Renovaro Biosciences Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

RENB Market Cap Formula = Stock Price * Shares Outstanding

The market cap of RENB helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

RENB Market Cap History

DateMarket CapChange
Dec 1, 2025$30.70M+52.06%
Nov 3, 2025$20.19M-93.87%
Oct 1, 2025$329.13M+715.54%
Sep 2, 2025$40.36M-11.99%
Aug 1, 2025$45.86M-4.96%
Jul 1, 2025$48.26M+2.49%
Jun 2, 2025$47.08M-6.33%
May 1, 2025$50.27M-38.17%
Apr 1, 2025$81.30M-43.90%
Mar 3, 2025$144.91M+17.08%
Feb 3, 2025$123.77M+0.03%
Jan 2, 2025$123.74M-6.30%

RENB End of Year Market Cap History

DateMarket CapChange
2025$25.08M-81.49%
2024$135.48M-34.95%
2023$208.27M+264.27%
2022$57.18M-85.10%
2021$383.70M+178.14%
2020$137.96M

FAQs About Renovaro Biosciences Inc (RENB) Market Cap

As of Dec 12, 2025, the market capitalization of RENB is $25.08M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Renovaro Biosciences Inc’s market capitalization has increased by 2.03%, changing from $24.58M to $25.08M as of Dec 12, 2025.

In the last 3 months, Renovaro Biosciences Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Renovaro Biosciences Inc’s market capitalization decreased from $208.27M in January to $135.48M in December, reflecting a -34.95% change.

In the past five years, RENB has had a compound annual growth rate (CAGR) of -0.36% in market capitalization. This means its market cap has shrunk at an average rate of -0.36% per year.

Renovaro Biosciences Inc (RENB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.